The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Perceptions and Preferences Regarding Multiple Sclerosis Research Among Racial and Ethnic Groups
Open accessAbstract
Background: For unclear reasons, minorities have been historically underrepresented in multiple sclerosis (MS) clinical trials. We hypothesized that different perceptions and preferences about research participation among racial and ethnic groups contribute to this imbalance. Methods: Members of the MS Minority Research Engagement Partnership Network developed a Web-based survey in English and Spanish on research impressions, concerns, and preferences regarding study attributes among people with MS. Invitations to take the survey were distributed by network members and partner organizations. Results: We included 2599 participants with MS (2111 White, 215 African American; 188 Hispanic). Consistently disliked study attributes included potential harms to health and confusing study information. Compared with White and non-Hispanic participants, respectively, African American (odds ratio [OR] = 2.05, P ≤ .001) and Hispanic (OR = 1.79, P = .003) participants were more concerned about being used by the research team. Hispanic participants were more concerned about research participation carrying risks to their legal status (OR = 1.70, P = .001). Hispanic (OR = 3.18, P ≤ .001) and African American (OR = 5.51, P ≤ .001) participants were more likely to prefer for the study to benefit their own racial/ethnic group. A top concern across all groups was not being fully informed about the research. Conclusions: We found strong support for research across racial and ethnic groups; however, minority groups have specific concerns regarding mistrust, receiving poor-quality care, unemployment, health insurance, and legal status. Investigators wanting to recruit a diverse study population are advised to show how they have addressed these concerns and to communicate how the research will advance the science and literature and result in better care and/or other benefits to underrepresented communities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Seven included studies centred on the recruitment of Hispanic or Latin American individuals.
“Although 7 studies centred on the recruitment of Hispanic or Latin American individuals [12, 15, 36, 50, 51, 57, 66], most of them did not differentiate between the terms Hispanic”
From Enablers and barriers of clinical trial participation in adult patients from minority ethnic groups: a systematic review (2025) · cites this paper as [57]
The Survey Dissemination section describes recruiting people with MS, and the Results report that 188 participants were Hispanic. But the Discussion describes the study as a survey of research perceptions across racial and ethnic groups, not one centred specifically on recruiting Hispanic or Latin American individuals. The count of seven refers to the citing paper’s group of studies, not a finding this individual source could establish. (LLM, conf=0.82)
Experimental — accuracy not yet measuredIn Pimentel Maldonado et al., participants who self-described as African American expressed concerns about data privacy, while participants who self-described as Hispanic reported concerns related to health insurance benefits or immigration status due to trial participation.
“In a study by Pimentel Maldonado et al. [57], participants who self-described as African American expressed concerns about data privacy, while participants who self-described as Hispanic reported concerns related to health insurance benefits or immigration status due to trial participation.”
From Enablers and barriers of clinical trial participation in adult patients from minority ethnic groups: a systematic review (2025) · cites this paper as [57]
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measuredGiven the cultural and experiential specificities rooted in the US, these findings are unlikely to be readily transferred and applied in other countries.
“Given the cultural and experiential specificities rooted in the US, these findings are unlikely to be readily transferred and applied in other countries [57, 74].”
From Enablers and barriers of clinical trial participation in adult patients from minority ethnic groups: a systematic review (2025) · cites this paper as [57]
The Results report that 92.89% of participants lived in the United States, and the discussion describes concerns that differed across racial and ethnic groups. Those passages support the study’s US-heavy and group-specific context, but the paper does not say its findings are unlikely to transfer to other countries. (LLM, conf=0.79)
Experimental — accuracy not yet measuredA total of 12 included articles were assessed with an MMAT score below 3, including two RCTs, three non-randomised studies, six quantitative descriptive studies and one mixed methods study.
“A total of 12 articles were assessed with a score of below 3. This included two RCTs [61, 66], three non-randomised studies [15, 46, 64], six quantitative descriptive studies [9, 37, 38, 40, 57, 58] and one mixed methods study [60].”
From Enablers and barriers of clinical trial participation in adult patients from minority ethnic groups: a systematic review (2025) · cites this paper as [57]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
George, S., Duran, N., & Norris, K. (2014) · American Journal of Public Health · doi:10.2105/ajph.2013.301706 · Cited by 1,603
Racial/ethnic differences in drug disposition and response: Review of recently approved drugs
Ramamoorthy, A., Pacanowski, M., Bull, J. C., & Zhang, L. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.61 · Cited by 341
Incidence of multiple sclerosis in multiple racial and ethnic groups
Langer-Gould, A. M., Brara, S. M., Beaber, B., & Zhang, J. L. (2013) · Neurology · doi:10.1212/wnl.0b013e3182918cc2 · Cited by 309
Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis
Cree, B., Khan, O., BOURDETTE, D. N., Goodin, D., Cohen, J. A., Marrie, R. A., Glidden, D. V., Weinstock‐Guttman, B., Reich, D., Patterson, N. J., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000145762.60562.5d · Cited by 302
Shavers, V. L., Lynch, C. F., & Burmeister, L. F. (2000) · PubMed · Cited by 239
The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex and service
Wallin, M. T., Culpepper, W. J., Coffman, P., Pulaski, S., Maloni, H., Mahan, C. M., Haselkorn, J. K., Kurtzke, J. F., & for the Veterans Affairs Multiple Sclerosis Centres of Excellence Epidemiology Group (2012) · Brain · doi:10.1093/brain/aws099 · Cited by 220
Does multiple sclerosis–associated disability differ between races?
Marrie, R. A., Cutter, G., Tyry, T. M., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000208505.81912.82 · Cited by 185
Minority Participation in Randomized Controlled Trials for Obsessive-Compulsive Disorder
Williams, M. T., Powers, M. B., Yun, Y. G., & Foa, E. B. (2009) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2009.11.004 · Cited by 156
Self-citationWhen will clinical trials finally reflect diversity?
Knepper, T. C., & McLeod, H. L. (2018) · Nature · doi:10.1038/d41586-018-05049-5 · Cited by 142
Rapid disease course in African Americans with multiple sclerosis
Kister, I., Chamot, E., Bacon, J. H., Niewczyk, P. M., Guzman, R. A. D., Apatoff, B., Coyle, P. K., Goodman, A. D., Gottesman, M. H., Granger, C. V., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e8e72a · Cited by 130
Weinstock‐Guttman, B., Jacobs, L., Brownscheidle, C. M., Baier, M. L., Rea, D. F., Apatoff, B. R., Blitz-Shabbir, K. M., Coyle, P. K., Frontera, A. T., Goodman, A. D., et al. (2003) · Multiple Sclerosis Journal · doi:10.1191/1352458503ms909oa · Cited by 125
Multiple sclerosis in US minority populations
Khan, O. A., Williams, M. J., Amezcua, L., et al. (2015) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000112 · Cited by 115
Self-citationPhenotype and prognosis in African-Americans with multiple sclerosis: a retrospective chart review
Naismith, R. T., Trinkaus, K. M., & Cross, A. H. (2006) · Multiple Sclerosis Journal · doi:10.1177/1352458506070923 · Cited by 100
Minority participation in Gynecologic Oncology Group (GOG) Studies
Scalici, J. M., Finan, M. A., Black, J., Harmon, M. D., Nicolson, W., Lankes, H. A., Brady, W. E., & Rocconi, R. P. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.05.014 · Cited by 98
Response to Interferon Beta-1a Treatment in African American Multiple Sclerosis Patients
Cree, B., Al‐Sabbagh, A., Bennett, R., et al. (2005) · Archives of Neurology · doi:10.1001/archneur.62.11.1681 · Cited by 87
Increased tissue damage and lesion volumes in African Americans with multiple sclerosis
Weinstock‐Guttman, B., Ramanathan, M. K., Hashmi, K., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181cff6fb · Cited by 67
Enrollment of women and minorities in NINDS trials
Burke, J. F., Brown, D. L., Lisabeth, L. D., Sánchez, B. N. G., & Morgenstern, L. B. (2011) · Neurology · doi:10.1212/wnl.0b013e3182088260 · Cited by 64
Retinal damage and vision loss in A frican A merican multiple sclerosis patients
Kimbrough, D. J., Sotirchos, E. S., Wilson, J. A., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24308 · Cited by 64
Multiple sclerosis management for low-income minorities
Shabas, D., & Heffner, M. (2005) · Multiple Sclerosis Journal · doi:10.1191/1352458505ms1215oa · Cited by 53
Ethnic Considerations and Multiple Sclerosis Disease Variability in the United States
Rivas-Rodríguez, E., & Amezcua, L. (2017) · Neurologic Clinics · doi:10.1016/j.ncl.2017.08.007 · Cited by 50
Self-citationIntentions to Donate to a Biobank in a National Sample of African Americans
McDonald, J. A., Vadaparampil, S. T., Bowen, D. J., Magwood, G., Obeid, J. S., Jefferson, M. S., Drake, R. R., Gebregziabher, M., & Halbert, C. H. (2014) · Public Health Genomics · doi:10.1159/000360472 · Cited by 46
Efficacy of Natalizumab Therapy in Patients of African Descent With Relapsing Multiple Sclerosis
Cree, B., Stuart, W. H., Tornatore, C., et al. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.45 · Cited by 42
Racial Differences Among Factors Associated with Participation in Clinical Research Trials
Kurt, A., Semler, L., Jacoby, J. L., Johnson, M. B., Careyva, B. A., Stello, B., Friel, T. J., Knouse, M. C., Kincaid, H. M., & Smulian, J. C. (2016) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-016-0285-1 · Cited by 38
MRI Correlates of Disability in African-Americans with Multiple Sclerosis
Howard, J., Battaglini, M., Babb, J. S., Arienzo, D., Holst, B., Omari, M., Stefano, N. D., Herbert, J., & Inglese, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043061 · Cited by 37
A Systematic Review of Race and Ethnicity in Hepatitis C Clinical Trial Enrollment
Wilder, J. M., Saraswathula, A., Hasselblad, V., et al. (2016) · Journal of the National Medical Association · doi:10.1016/j.jnma.2015.12.004 · Cited by 36
Buchanan, R. J., Zuniga, M. A., Carrillo, G., Chakravorty, B. J., Tyry, T. M., Moreau, R. L., & Vollmer, T. L. (2011) · Journal of Social Work in Disability & Rehabilitation · doi:10.1080/1536710x.2011.622959 · Cited by 14
Flagged first, then by citations
Cited by
Sorted by citations
Alarcón Garavito, G. A., Gilchrist, K., Ciurtin, C., Khanna, S., Chambers, P., McNally, N., Merivale, E., Carr, E., Yu, R., & Vindrola-Padros, C. (2025) · Trials · doi:10.1186/s13063-025-08769-y · Cited by 42
“…m e m b e r s a r e d i s c o u r a g e d f r o m p a r t i c i p a t i n g i n s t u d i e s d u e t o m i s t r u s t , c o n c e r n s a b o u t r e c e i v i n g p oo r ‑ q u a l i t y m e d i c a l c a r e a n d r i s k s t o i n s u r a n c e c o v e r a g e o r l e g a l s t a t u s [ 57 ] –”
Influential
Metadata
- Authors
- Pimentel Maldonado, D. A., Moreno, A., Williams, M. J., Amezcua, L., Feliciano, S., Williams, A., Machemer, D., Livingston, T., LaRocque, M., Glim, M., & Schmidt, H.
- Affiliations
- University of Southern California (US)
- ORCID
- Venue
- International Journal of MS Care
- Published
- 2021-01-12
- Volume
- 23
- Issue
- 4
- Pages
- 170-177
- ISSN
- 1537-2073 (ISSN-L)
- PMC
- PMC8405146
- OpenAlex
- W3120368406
- Cited by
- 29
- References
- 26
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 5 · 2023: 10 · 2022: 1 · 2021: 3
- FWCI
- 4.12
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- International Journal of MS Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Patient-Centered Outcomes Research Institute
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Social Sciences › Anthropology › Race, Genetics, and Society
- Keywords
- multiple sclerosis, racial and ethnic disparities, clinical trial recruitment, mistrust of research, African American patients, Hispanic patients, health insurance, unemployment, underrepresented groups
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review